RogerOveMDPhD

PubMed

• 3567 citations
  Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
  James A. Bonner, Paul M. Harari, Jordi Giralt, Nozar Azarnia, Dong M. Shin
  The New England Journal of Medicine. 2006-02-09
• 72 citations
  Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.
  Richard A. Popple, Roger Ove, Sui Shen
  International Journal of Radiation Oncology, Biology, Physics. 2002-11-01
• 20 citations
  Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
  William H. Chappell, Saverio Candido, Stephen L. Abrams, Suzanne Russo, Roger Ove
  Advances in Biological Regulation. 2018-05-18

Journal Articles

• Variation of Neck Position with Image Guided Radiotherapy for Head and Neck Cancer  
  Ove R, Calavieri R, Noble D, Russo S, Am J Clin Oncol. 35 (1): 1-5
• Pulse-Reduced Dose Rate for the Retreatment of Recurrent Head and Neck Cancer.  
  Russo S. and Ove R, Mitchell Cancer Institute Research Symposium
• Instability of Some Black Holes  
  Detweiler S and Ove R, Physical Review Letters, 51, Number 67
• Instability of the Kerr Solution of Fourth Order Gravity.  
  Hersh J and Ove R, Physics Letters, 156B, 305
• Symmetry and Singularity Formation in Expanding Spacetimes.  
  Ove R, Physical Review D
• Properties of a Model Einstein Equation.  
  Ove R, General Relativity and Gravitation, 22, Number 6, 631
• Properties of a Model Einstein Equation.  
  Ove R, General Relativity and Gravitation, 22, Number 6, 631
• Nonlinear Gravitational Effect.  
  Ove R, Physical Review Letters, 64, Number 11, 1200
• Anisotropic Effective Core Potentials.  
  Sellers H and Ove R, Chemical Physics Letters, 170, 523
• Analysis of Cosmological Gravitational Wave Residue.  
  Ove R, Classical and Quantum Gravity, 7, 2225
• Analysis of Cosmological Gravitational Wave Residue.  
  Ove R, Classical and Quantum Gravity, 7, 2225
• Anomalous Foliations of Einstein Space-times.  
  Ove R, Journal of Mathematical Physics, 31, Number 11, 2688
• Adjuvant Trials for Pancreatic Cancer: Where Are We Going and What is Needed?  
  Russo S, Ove R, Saif MW, Clinical Investigation, 1 (5); 661-667
• Identification of Prognostic and Predictive Markers in Pancreatic Adenocarcinoma: 2011 ASCO Gastrointestinal Cancer Symposium.  
  Russo SM, Ove R, Saif MW, JOP, 12 (2); 92-95
• Hybrid Cyberknife/IMRT Radiotherapy for Peri-sellar Tumors.  
  Ove R, Galle JO, Vincent AJ, Russo SM, Martino AM, Journal of Radiation Oncology
• Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Pathways: Therapeutic Targets for Controlling Cancer Growth.  
  McCubrey JA, Steelman LS, Abrams SL, Chappell WH, Russo S, Ove R, Milella M, Tafuri A, Lunghi P, Bonati A, Stivala F, Nicoletti F, Libra M, Martelli AM, Montalto G, C..., Expert Opin Emerg Drugs
• The Multidisciplinary Treatment of Non-Metastatic Pancreatic Cancer: A Review.  
  Russo S, Ove R, Blackstock AW, Cancer Therapy, 6: 341-357
• New Approaches to Postoperative Radiotherapy for Cancer of the Head and Neck.  
  Prellop P and Ove R, Current Cancer Therapy Reviews, 1, number 1, 63-70
• Intensity Modulated Radiotherapy for Carcinoma of the Maxillary Sinus.  
  Ahmed R, Ove R, Duan J, Popple R, and Cobb GB, Medical Dosimetry, 31 (3); 224-32
• Gene Therapy-induced Augmentation of Epidermal Growth Factor Receptor (EGFr) Enhances the Radiosensitization Properties of Anti-EGFr Treatment in Prostate Cancer Cells.  
  Int. J. Radiat. Biol., 75, Number 5, 529-541, International Journal of Radiation Oncology, Biology, Physics, 58, number 3, 950-958
• Delayed expression of hpS2 and prolonged expression of CIP1/WAF1/SDI1 in human tumor cells irradiated with X-rays, fission neutrons, or 1 GeV/n Fe-ions.  
  Balcer-Kubiczek EK, Zhang XF, Harrison GH, Zhou XJ, Vigneulle RM, Ove R, McCready WA, Xu JF, Int. J. Radiat. Biol., 75, Number 5, 529-541
• Tomographic Convolutional Dosimetry of Interstitial Brachytherapy Implants.  
  Ove R, Medical Physics, 26, Number 6
• Postoperative Endoscopic Retrograde HDR Brachytherapy for Cholangiocarcinoma.  
  Ove R, Kennedy AS, Darwin P, and Haluszka O, American Journal of Clinical Oncology, 23, Number 6, 559-61
• Preservation of Visual Fields after Peri-sellar Gamma-Knife Radiosurgery.  
  Ove R, Kelman S, Amin P, and Chin LS, International Journal of Cancer, 90, Number 6, 343-350
• Inverse Treatment Planning for Gamma Knife Radiosurgery.  
  Shepard DM, Ferris MC, Ove R, and Ma L, Medical Physics, 27, Number 12, 2748-56
• Join now to see all

Books/Book Chapters

• Novel Anticancer Agents, Strategies for Discovery and Clinical Testing. 
  Chapter: Molecular Targets for Radiosensitization 
  Page 391 - 414Ove R and Bonner JAEditors: Adjei AA and Buolamwini JK.Elsevier Academic Press
• Clinical Radiation Oncology. 
  Chapter: Nasopharyngeal Carcinoma 
  Ove R, Foote RL, and Bonner JAEditors: Gunderson LL and Tepper JE.Elsevier Churchill LivingstoneEdition 2,
• Radiation Oncology: An Evidence-Based Approach. 
  Chapter: Thyroid Cancer 
  Ove R and Allison RREditors: Lu JJ and Brady LW.Springer
• Nasopharyngeal Cancer- Multidisciplinary Management. 
  Chapter: Early Stage Nasopharyngeal Cancer: A Highly Curative Disease with Radiation Therapy 
  Ove R, Allison RR, and Lu JJEditors: Lu JJ and Brady LW.Springer
• Radiation Oncology: An Evidence-Based Approach. 
  Chapter: Thyroid Cancer 
  Ove R and Drake AEditors: JJ and Brady LW.Springer
• Adverse Radiation Effects on the Pancreas in Adverse Late effects of Radiation Treatment (ALERT). 
  Russo S, Ove R, Fajardo L, Tepper JEditors: Philip Rubin, Louis Constine, Larry Marks, Laura Dawson, Debra Friedma0n, Zeljko Vujaskovic ......WB Saunders
• Clinical Radiation Oncology. 
  Chapter: Nasopharyngeal Carcinoma 
  Lee N, Laufer M, Ove R, Foote RL, and Bonner JAEditors: Gunderson LL and Tepper JE.Elsevier Churchill LivingstoneEdition 3,
• Frontiers of Numerical Relativity. 
  Chapter: An Algorithmic Overview of an Einstein Solver 
  Ove REditors: Evans, Finn, & Hobill.Cambridge University Press
• Dynamical Spacetimes and Numerical Relativity. 
  Chapter: Numerical Investigations of Cosmic Censorship on T3xR 
  Ove REditors: J. Centrella.Cambridge University Press
• Join now to see all

Abstracts/Posters

• Cox-2 inhibition and chemoradiation for squamous cell carcinoma of the head and neck.
  Spencer S, Nabell L, Bonner J, Peters G, Carroll WL, Meredith R, Clemons L, Ove R, ASCO
• Evaluation of the PSMA Promoter for use in a Conditionally Replicative Adenovirus (CRAd).
  Ove R, Swift A, Nettlebeck DM, Yamamato M, Krasnykh VN, and Curiel DT, Radiation Research Society, Brisbane Australia
• Combination Radiation and Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer.
  Bonner JA, Raisch KP, Buchsbaum DJ, Giralt J, Ove R, Spencer SA, Azamia N, Robert F, Chemotherapy Foundation Symposium XXII, New York, Cancer Investigation, 23
• Regional nodal failure in squamous cell carcinoma of the nasal cavity.
  Prellop P, Ove R, and Peters G, American Society for Therapeutic Radiology and Oncology
• Radiation Tolerance of the Optic Apparatus.
  Cook B, Withrow LA, Spencer SA, Ove R, and Fiveash JB, American Society for Therapeutic Radiology and Oncology
• Dose Overestimation in Balloon Catheter Brachytherapy for Breast Cancer.
  Ye S, Ove R, Shen S, Russo S, and Brezovich I, American Society for Therapeutic Radiology and Oncology
• Dose Non-Uniformity on Prescription Surface and Skin for Balloon Catheter Brachytherapy for Breast Cancer.
  Ye S, Ove R, Kim S, Shen S, Duan J, and Brezovich I, American Association of Physics in Medicine
• Radiosensitization with a Cox-2 inhibitor, with Chemoradiation for Cancer of the Head and Neck.
  George J, Peters G, Carroll W, Nabell L, and Ove R, Proceedings of the American Society of Clinical Oncology (ASCO)
• The relationship of Cetuximab-induced rash and survival in patients with head and neck cancer treated with radiotherapy and cetuximab.
  Bonner JA, Harari PM, Giralt J, Cohen R, Baselga J, Raben D, Shin DM, Ove R, Jassem J, Amellal N, Azarnia N, Ang KK, American Society for Therapeutic Radiology and Oncology
• Induction Chemotherapy followed by Concomitant Docetaxel with Concomitant Boost Radiotherapy (CBR) for Cancer of the Head and Neck.
  Prellop P, Ove R, Meredith R, Bonner JA, Peters G, Carroll W, Spencer SA, Nabell L, ASCO
• Multi-centre Clinical Assessment of Auto-contouring using Deformable Image Registration for Adaptive Therapy.
  Gooding MJ, Conibear J, Dilling T, Fuss M, Gujral D, Ove R, Stevens C, Kadir T, ASTRO. Altlanta
• Intensity-Modulated and Image-Guided Radiation therapy (IMRT/IGRT) Salvage for Rising Post-Prostatectomy PSA: Outcomes and Morbidity.
  Allison R, Dairkee, U, Gay H, Ove R, Frelix G, Arastu H, Murphy G, ASTRO, Boston MA
• Variation of Neck Position with Image Guided Radiotherapy for Head and Neck Cancer.
  Ove R. Cavalieri R, ASTRO, Boston MA
• UAB-0210: A Phase I/II trial of induction chemotherapy followed by concomitant docetaxel/radiotherapy with subcutaneous amifostine for advanced squamous cell carcinoma...
  Nabell L, Peters G, Meredith R, Carroll W, Bonner J, Ove R, Spencer S, ASCO
• Selective Neck IMRT for Locally Advanced Head and Neck Carcinoma.
  R. Ove, M. E. Couch, P. S. Camnitz, S. M. Russo, D. Noble, J. G. Rosenman, RSNA, Chicago
• Hypofractionation Approaches in Radiation Therapy.
  R. Ove, Oncology Outlook, Point Clear, Alabama
• Pulse-Reduced Dose Rate for the Retreatment of Recurrent Head and Neck Cancer.
  Russo S. and Ove R, ASTRO Head and Neck Symposium. Phoenix Arizona
• Hybrid Cyberknife/IMRT Radiotherapy for Pituitary Macroadenoma.
  Galle J., Vincent A., Russo S., Martino A., Ove R, RSNA. Chicago Ill
• Multi-centre clinical assessment of atlas-based contouring. ASTRO.
  Gooding MJ, Conibear J, Dilling T, Fuss M, Gujral D, Ove R, Stevens C, Kadir T, Atlanta
• Join now to see all